BR9405892A - Compostos de amino insaturados para uso como agente anti-câncer e anti-protozoários - Google Patents

Compostos de amino insaturados para uso como agente anti-câncer e anti-protozoários

Info

Publication number
BR9405892A
BR9405892A BR9405892A BR9405892A BR9405892A BR 9405892 A BR9405892 A BR 9405892A BR 9405892 A BR9405892 A BR 9405892A BR 9405892 A BR9405892 A BR 9405892A BR 9405892 A BR9405892 A BR 9405892A
Authority
BR
Brazil
Prior art keywords
pct
carbon atom
bonding
nitrogen
cancer
Prior art date
Application number
BR9405892A
Other languages
English (en)
Inventor
Joerg Frei
Jaroslav Stanek
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of BR9405892A publication Critical patent/BR9405892A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/22—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/23—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton the carbon skeleton containing carbon-to-carbon triple bonds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
BR9405892A 1993-12-27 1994-12-14 Compostos de amino insaturados para uso como agente anti-câncer e anti-protozoários BR9405892A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH387693 1993-12-27
EP9404320 1994-12-14

Publications (1)

Publication Number Publication Date
BR9405892A true BR9405892A (pt) 1995-12-12

Family

ID=4265390

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9405892A BR9405892A (pt) 1993-12-27 1994-12-14 Compostos de amino insaturados para uso como agente anti-câncer e anti-protozoários

Country Status (13)

Country Link
US (1) US5627215A (pt)
EP (1) EP0686143B1 (pt)
JP (1) JPH08507548A (pt)
CN (1) CN1121707A (pt)
AT (1) ATE169614T1 (pt)
AU (1) AU690618B2 (pt)
BR (1) BR9405892A (pt)
CA (1) CA2155095A1 (pt)
DE (1) DE69412467T2 (pt)
DK (1) DK0686143T3 (pt)
ES (1) ES2119371T3 (pt)
NZ (1) NZ277503A (pt)
WO (1) WO1995018091A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184232B1 (en) * 1986-12-02 2001-02-06 University Of Florida Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment
JP3891496B2 (ja) * 1996-10-18 2007-03-14 ウイスコンシン アルムニ リサーチ ファウンデイション 立体配座的に制限のあるポリアミン類
US5889061A (en) * 1997-10-15 1999-03-30 Wisconsin Alumni Research Foundation Conformationally restricted polyamines
WO2000066587A2 (en) * 1999-04-30 2000-11-09 Slil Biomedical Corporation Polyamines and their use in therapy
MXPA01011008A (es) * 1999-04-30 2003-06-30 Slil Biomedical Corp Conjugados analogos de poliamina y conjugados de quinona novedosos como terapia para canceres y enfermedades de la prostata.
US6482943B1 (en) 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
US6649587B1 (en) 1999-04-30 2003-11-18 Slil Biomedical Corporation Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
WO2002091989A2 (en) 2000-11-08 2002-11-21 Slil Biomedical Corporation Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
WO2003033455A1 (en) 2001-10-16 2003-04-24 Slil Biomedical Corporation Oligoamine compounds and derivatives thereof for cancer therapy
US6982351B2 (en) 2001-12-07 2006-01-03 Cellgate, Inc. Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
MXPA04007584A (es) * 2002-02-07 2004-12-06 Wisconsin Alumni Res Found Compuestos de poliamina y composiciones para su uso en conjunto con una terapia contra el cancer.
WO2005014524A2 (en) * 2003-08-07 2005-02-17 Wisconsin Alumni Research Foundation Amino thiol compounds and compositions for use in conjunction with cancer therapy
KR101050328B1 (ko) 2004-08-31 2011-07-19 엘지디스플레이 주식회사 램프 및 이를 구비한 백라이트 구동장치
EP1940773B1 (en) * 2005-08-10 2015-03-18 Johns Hopkins University Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
US20130102556A1 (en) * 2010-02-02 2013-04-25 The Johns Hopkins University Use of N1,N4-bis[3-(Ethylamino)Propyl]-2-Butene-1,4-Diamine Compounds in Combination with Epigenetic-Acting Pharmaceuticals for Enhanced Cancer Therapy
CN102212013A (zh) * 2011-03-30 2011-10-12 广东中科药物研究有限公司 一种多胺化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2991290A (en) * 1957-03-20 1961-07-04 Us Vitamin Corp Nu-alkylamino-alpha-hydroxy-alkanoic acid amides
US4278605A (en) * 1980-06-30 1981-07-14 American Cyanamid Company Heteroalkylenebisanthraquinones
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
CA1305425C (en) * 1986-12-02 1992-07-21 Raymond J. Bergeron Anti-neoplastic spermine derivative
AU602186B2 (en) * 1987-02-03 1990-10-04 Merrell Dow Pharmaceuticals Inc. Novel polyamine derivatives
US4935449A (en) * 1988-08-04 1990-06-19 Merrell Dow Pharmaceuticals Inc. N-2,3-butadienyl tri- and tetraaminoalkane derivatives
JPH02118405A (ja) * 1988-10-27 1990-05-02 Nec Yamagata Ltd 微小寸法測定装置
GB9115375D0 (en) * 1991-07-17 1991-09-04 Salutar Inc Compounds

Also Published As

Publication number Publication date
EP0686143A1 (en) 1995-12-13
US5627215A (en) 1997-05-06
NZ277503A (en) 1997-07-27
EP0686143B1 (en) 1998-08-12
WO1995018091A1 (en) 1995-07-06
DE69412467T2 (de) 1999-01-28
ES2119371T3 (es) 1998-10-01
DK0686143T3 (da) 1999-05-17
JPH08507548A (ja) 1996-08-13
CA2155095A1 (en) 1995-07-06
DE69412467D1 (de) 1998-09-17
AU1274495A (en) 1995-07-17
AU690618B2 (en) 1998-04-30
CN1121707A (zh) 1996-05-01
ATE169614T1 (de) 1998-08-15

Similar Documents

Publication Publication Date Title
ES2119371T3 (es) Aminocompuestos insaturados para usar como un agente anticancerigeno y antiprotozoico.
IL103665A (en) Analogues of sulfasalazine and their use in the preparation of a medicament having therapeutic effect against autoimmune diseases
UY28374A1 (es) Agentes terapéuticos
BRPI0407329A (pt) Derivados de pirimidina para a prevenção de infecção de hiv
AR038045A1 (es) Agentes terapeuticos
CA2304713A1 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
MX2007007220A (es) Compuestos de pirazolona como agonistas de receptor de glutamato metabotropico para el tratamiento de trastornos neurologicos y psiquiatricos.
KR960034164A (ko) 스틸벤 유도체 및 이를 함유하는 약제학적 조성물
PE20011166A1 (es) Piridinas, pirimidinas, purinonas, pirrolopirimidinonas y pirrolopiridinonas como antagonistas del factor liberador de corticotropina
TWI265928B (en) A61k 31/4025 200601 a i htw a61p 25/00 200601 a n htw
MX9302704A (es) Metodo para proporcionar un efecto antihistaminico en un paciente lesionado hepaticamente.
UY28377A1 (es) Agentes terapeuticos
DE69507476D1 (de) Farnesyl-transferase-inhibitoren, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
BR0113590A (pt) 7-oxo-piridopirimidinas
HUP0301733A2 (hu) Aktivitásfokozó adjuvánsokat tartalmazó agrokémiai készítmények és alkalmazásuk
DK0667864T3 (da) Tricykliske forbindelser med farmaceutisk virkning
UA41880C2 (uk) Серотонінергічні похідні ерголіну і фармацевтична композиція
KR960003719A (ko) 녹내장 치료제 및 안압 강하제
AR057461A1 (es) Derivados de pirazol, proceso de preparacion, composiciones farmaceuticas y usos
CA2438506A1 (en) Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
ES2194412T3 (es) Uso de derivados de hidantoina para la preparacion de un medicamento para el tratamiento de vasculitis resistente al tratamiento.
HN2001000119A (es) S-metil-dihidro -ziprasidona para el tratamiento de trastornos psiquiatricos y oculares.
ATE172959T1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
IL160785A0 (en) Tetrahydropyran derivatives and their use as therapeutic agents
ATE169021T1 (de) Cephalostatin-analoga und ihre verwendung als antitumormittel

Legal Events

Date Code Title Description
PC Transfer

Free format text: NOVARTIS AG (NOVARTIS SA) (NOVARTIS INC.) (CH)

EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal